Evidence map›Paper›PMID 36264885›Full record

ArticleAmerican journal of physiology. Renal physiology2022

Promises and challenges of miRNA therapeutics.

Jianyin Long, Farhad R Danesh

Abstract readEditorialComment
In one paragraph

Article in American journal of physiology. Renal physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. The Role of microRNAs in Inflammatory Bowel Disease.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Review
  8. RNA Structure: Past, Future, and Gene Therapy Applications.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. miRNA-Based Technologies in Cancer Therapy.Journal of personalized medicine · 2023
    Review
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jianyin LongSection of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Farhad R DaneshSection of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-6849-5239

Funding

MicroRNA In Diabetic NephropathyR01DK091310 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DANESH, FARHAD R · 2011 to 2024
$5.3M
Role of Rho Kinases in Diabetic NephropathyR01DK078900 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DANESH, FARHAD R · 2009 to 2024
$5.2M
NIDDK NIH HHS R01 DK078900NIDDK NIH HHS R01 DK091310
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MicroRNAsMolecular Targeted TherapyMicroRNAskidneymicroRNAsobesityRNAtherapeutics

Identifiers

PMID36264885
PMCPMC9705016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.